Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who have received prior cisplatin-based therapy

被引：0

作者：

Shinohara, N

Suzuki, S

Abe, T

Sazawa, A

Harabayashi, T

Nonomura, K

机构：

来源：

JOURNAL OF UROLOGY | 2005年 / 173卷 / 04期

关键词：

D O I：

10.1016/S0022-5347(18)35464-8

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

1319

引用

页码：358 / 358

页数：1

共 50 条

[31] Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix
Choi, C. H.
Kim, T. -J.
Leey, S. -J.
Lee, J. -W.
Kim, B. -G.
Lee, J. -H.
Bae, D. -S.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (03) : 1157 - 1164
[32] Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer
Galsky, Matthew D.
Krege, Susan
Lin, Chia-Chi
Hahn, Noah
Ecke, Thorsten H.
Moshier, Erin
Sonpavde, Guru
Godbold, James
Oh, William K.
Bamias, Aristotle
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 30.e15 - 30.e21
[33] Salvage chemotherapy with cisplatin, ifosfamide, and paclitaxel in metastatic castration-resistant prostate cancer.
Von Amsberg, Gunhild
Zilles, Mirjam
Gild, Philipp
Alsdorf, Winfried
Boeckelmann, Lukas
Langebrake, Claudia
Oh-Hohenhorst, Su Jung
Tilki, Derya
Graefen, Markus
Dyshlovoy, Sergey
Bokemeyer, Carsten
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
[34] Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy
Mitani, Akihisa
Jo, Taisuke
Yasunaga, Hideo
Sakamoto, Yukiyo
Hasegawa, Wakae
Urushiyama, Hirokazu
Yamauchi, Yasuhiro
Matsui, Hiroki
Fushimi, Kiyohide
Nagase, Takahide
ANTI-CANCER DRUGS, 2018, 29 (06) : 560 - 564
[35] SALVAGE CHEMOTHERAPY WITH PACLITAXEL, IFOSFAMIDE AND NEDAPLATIN (TIN) FOR REFRACTORY OR RELAPSED GERM CELL TUMORS IN PATIENTS WITH IMPAIRED RENAL FUNCTION
Shiraishi, Takumi
Nakamura, Terukazu
Oishi, Masakatsu
Ueda, Takashi
Nakanishi, Hiroyuki
Naya, Yoshio
Hongo, Fumiya
Kamoi, Kazumi
Okihara, Koji
Ukimura, Osamu
JOURNAL OF UROLOGY, 2016, 195 (04): : E841 - E841
[36] The combination chemotherapy of docetaxel, ifosfamide, and cisplatin (DIP) in patients with advanced urothelial cancer
Takahashi, S
Suzuki, M
Tomita, K
Takeuchi, T
Ohta, N
Kitamura, T
JOURNAL OF UROLOGY, 2004, 171 (04): : 83 - 83
[37] Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy
Kawano, Kouichiro
Tsuda, Naotake
Waki, Kayoko
Matsueda, Satoko
Hata, Yoshiro
Ushijima, Kimio
Itoh, Kyogo
Yamada, Akira
Kamura, Toshiharu
CANCER SCIENCE, 2015, 106 (09) : 1111 - 1117
[38] Prognostic model for overall survival in patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy
Galsky, Matt D.
Krege, Susanne
Lin, Chia-Chi
Hahn, Noah M.
Ecke, Thorsten
Moshier, Erin L.
Sonpavde, Guru
Godbold, James H.
Oh, William K.
Bamias, Aristotelis
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[39] Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy
Apolo, Andrea B.
Ostrovnaya, Irina
Halabi, Susan
Iasonos, Alexia
Philips, George K.
Rosenberg, Jonathan E.
Riches, Jamie
Small, Eric J.
Milowsky, Matthew I.
Bajorin, Dean F.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (07): : 499 - 503
[40] Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
von Amsberg, Gunhild
Zilles, Mirjam
Mansour, Wael
Gild, Philipp
Alsdorf, Winfried
Kaune, Moritz
Boeckelmann, Lukas
Hauschild, Jessica
Krisp, Christoph
Rohlfing, Tina
Saygi, Ceren
Alawi, Malik
Zielinski, Alexandra
Langebrake, Claudia
Oh-Hohenhorst, Su Jung
Perner, Sven
Tilki, Derya
Schlueter, Hartmut
Graefen, Markus
Dyshlovoy, Sergey A.
Bokemeyer, Carsten
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)

← 1 2 3 4 5 →